Pancreatic cancer screening study for healthy adults
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial is studying a new screening method (LINFU®) to find pancreatic cancer early in people who have no symptoms or known risk factors, to see if it can help detect cancer in the general population.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 89 years old.
- You have no symptoms of pancreatic cancer, such as jaundice, weight loss, or abdominal pain.
- You have no known risk factors for pancreatic cancer, like family history or chronic pancreatitis.
- You do not drink more than 3 alcoholic drinks a day or have a history of heavy drinking.
- You have never been diagnosed with adult-onset diabetes, are not obese (BMI under 30), and have not smoked or used tobacco for more than a year.
- You are not pregnant, and you can safely undergo procedures like endoscopy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.